Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

HLA-G expression in B chronic lymphocytic leukemia: a new prognostic marker?
Alev Akyol Erikçi, Bülent Karagöz, Mustafa Özyurt, et al.
Hematology (2009) Vol. 14, Iss. 2, pp. 101-105
Open Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

HLA-G
Edgardo D. Carosella, Nathalie Rouas‐Freiss, Diana Tronik‐Le Roux, et al.
Advances in immunology (2015), pp. 33-144
Closed Access | Times Cited: 341
Use of Allogeneic NK Cells for Cancer Immunotherapy
Melissa A. Geller, Jeffrey S. Miller
Immunotherapy (2011) Vol. 3, Iss. 12, pp. 1445-1459
Open Access | Times Cited: 147
Biology of HLA-G in cancer: a candidate molecule for therapeutic intervention?
Laurence Amiot, Soldano Ferrone, Hans Grosse‐Wilde, et al.
Cellular and Molecular Life Sciences (2010) Vol. 68, Iss. 3, pp. 417-431
Open Access | Times Cited: 133
Role of HLA-G in tumor escape through expansion of myeloid-derived suppressor cells and cytokinic balance in favor of Th2 versus Th1/Th17
Sophie Agaugué, Edgardo D. Carosella, Nathalie Rouas‐Freiss
Blood (2011) Vol. 117, Iss. 26, pp. 7021-7031
Closed Access | Times Cited: 132
Human Leukocyte Antigen-G (HLA-G) Expression in Cancers: Roles in Immune Evasion, Metastasis and Target for Therapy
Aifen Lin, Wei‐Hua Yan
Molecular Medicine (2015) Vol. 21, Iss. 1, pp. 782-791
Open Access | Times Cited: 120
Immune Response Dysfunction in Chronic Lymphocytic Leukemia: Dissecting Molecular Mechanisms and Microenvironmental Conditions
Francesca Arruga, Benjamin B. Gyau, Andrea Iannello, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 5, pp. 1825-1825
Open Access | Times Cited: 114
The Dual Role of HLA-G in Cancer
Nathalie Rouas‐Freiss, Philippe Moreau, Joël LeMaoult, et al.
Journal of Immunology Research (2014) Vol. 2014, pp. 1-10
Open Access | Times Cited: 106
The Role of HLA-G Molecule and HLA-G Gene Polymorphisms in Tumors, Viral Hepatitis, and Parasitic Diseases
Fabrício C. Dias, Erick C. Castelli, Cristhianna V. A. Collares, et al.
Frontiers in Immunology (2015) Vol. 6
Open Access | Times Cited: 71
The mystery of chronic lymphocytic leukemia (CLL): Why is it absent in Asians and what does this tell us about etiology, pathogenesis and biology?
Shenmiao Yang, Jianyong Li, Robert Peter Gale, et al.
Blood Reviews (2014) Vol. 29, Iss. 3, pp. 205-213
Closed Access | Times Cited: 70
HLA-G Neo-Expression on Tumors
Maria Loustau, François Anna, Raphaelle Dréan, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 58
HLA-G and Other Immune Checkpoint Molecules as Targets for Novel Combined Immunotherapies
Fabio Morandi, Irma Airoldi
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 2925-2925
Open Access | Times Cited: 30
Perspectives of targeting LILRB1 in innate and adaptive immune checkpoint therapy of cancer
Tobias Zeller, Ira A. Münnich, Roland Windisch, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 18
Tumor immunosuppressive environment: effects on tumor-specific and nontumor antigen immune responses
Ana Paula Duarte de Souza, Cristina Bonorino
Expert Review of Anticancer Therapy (2009) Vol. 9, Iss. 9, pp. 1317-1332
Closed Access | Times Cited: 71
Human leukocyte antigen-G in cancer: Are they clinically relevant?
Wei‐Hua Yan
Cancer Letters (2011) Vol. 311, Iss. 2, pp. 123-130
Closed Access | Times Cited: 58
Serum sHLA‐G levels: A useful indicator in distinguishing colorectal cancer from benign colorectal diseases
Cheng‐Bao Zhu, C.-X. Wang, Xin Zhang, et al.
International Journal of Cancer (2010) Vol. 128, Iss. 3, pp. 617-622
Open Access | Times Cited: 54
HLA-G is a component of the chronic lymphocytic leukemia escape repertoire to generate immune suppression: impact of the HLA-G 14 base pair (rs66554220) polymorphism
Roberta Rizzo, Valentina Audrito, Paola Vacca, et al.
Haematologica (2013) Vol. 99, Iss. 5, pp. 888-896
Open Access | Times Cited: 49
Tumor-induced host immunosuppression: Special focus on CLL
Christine E. Cutucache
International Immunopharmacology (2013) Vol. 17, Iss. 1, pp. 35-41
Closed Access | Times Cited: 35
Importance of HLA-G expression and tumor infiltrating lymphocytes in molecular subtypes of breast cancer
Dandan Dong, Shang-mian Yie, Ke Li, et al.
Human Immunology (2012) Vol. 73, Iss. 10, pp. 998-1004
Closed Access | Times Cited: 34
Natural Killer Cells in Chronic Lymphocytic Leukemia: Functional Impairment and Therapeutic Potential
Max Yano, John C. Byrd, Natarajan Muthusamy
Cancers (2022) Vol. 14, Iss. 23, pp. 5787-5787
Open Access | Times Cited: 14
Soluble human leukocyte antigen-G expression in patients with ductal and lobular breast malignancy.
Xeni Provatopoulou, Eleni Kalogera, Alexandros Sagkriotis, et al.
PubMed (2012) Vol. 32, Iss. 3, pp. 1021-6
Closed Access | Times Cited: 32
NK Cells in Chronic Lymphocytic Leukemia and Their Therapeutic Implications
Paolo Sportoletti, Filomena De Falco, Beatrice Del Papa, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 6665-6665
Open Access | Times Cited: 19
HLA-G expression in acute lymphoblastic leukemia: a significant prognostic tumor biomarker
Noura Alkhouly, Iman H. Shehata, Manal Basyouni Ahmed, et al.
Medical Oncology (2013) Vol. 30, Iss. 1
Closed Access | Times Cited: 23
Trogocytic intercellular membrane exchanges among hematological tumors
Joël LeMaoult, Julien Caumartin, Marina Daouya, et al.
Journal of Hematology & Oncology (2015) Vol. 8, Iss. 1
Open Access | Times Cited: 22
Tumor-specific upregulation of human leukocyte antigen–G expression in bladder transitional cell carcinoma
Gan Ling-hong, Lifu Huang, Xia Zhang, et al.
Human Immunology (2010) Vol. 71, Iss. 9, pp. 899-904
Closed Access | Times Cited: 23
HLA-G expression in hematologic malignancies
Wei‐Hua Yan
Expert Review of Hematology (2010) Vol. 3, Iss. 1, pp. 67-80
Closed Access | Times Cited: 22
Page 1 - Next Page

Scroll to top